The EMI study: A regional feasibility study for a randomised trial of adjuvant chemotherapy following definitive treatment for transitional cell cancer (TCC) of the bladder.

被引：0
|
作者：
Leahy, MG
Brown, J
Jones, WG
Kelly, J
Neal, DE
Prescott, S
Roberts, T
Selby, P
机构：
[1] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England
[2] Leeds Canc Ctr, Leeds, W Yorkshire, England
[3] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England
[4] Leeds Teaching Hosps NHS Trust, Leeds, W Yorkshire, England
[5] Canc Res UK, Ctr Clin, Leeds, W Yorkshire, England
来源：
BRITISH JOURNAL OF CANCER | 2002年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [1] The EMI study: A regional feasibility study for a randomised trial of adjuvant chemotherapy following definitive treatment for transitional cell cancer (TCC) of the bladder.
    Leahy, MG
    Brown, J
    Jones, WG
    Kelly, J
    Neal, DE
    Prescott, S
    Roberts, T
    Selby, P
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 : S23 - S23
  • [2] Intravesical gemcitabine (G) single agent as adjuvant chemotherapy in superficial transitional cell carcinoma (TCC) of bladder.
    Bouzid, K
    Ferhat, R
    Bounedjar, A
    Mahfouf, H
    Smaili, F
    Adjali, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 407S - 407S
  • [3] The impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients (pts) with transitional cell carcinoma (TCC) of the bladder.
    Dash, A
    Koppie, T
    Vora, K
    Bochner, B
    Galsky, MD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 399S - 399S
  • [4] Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer
    Murthy, V.
    Maitre, P.
    Singh, M.
    Pal, M.
    Arora, A.
    Pujari, L.
    Kapoor, A.
    Pandey, H.
    Sharma, R.
    Gudipudi, D.
    Joshi, A.
    Prabhash, K.
    Noronha, V.
    Menon, S.
    Mehta, P.
    Bakshi, G.
    Prakash, G.
    [J]. CLINICAL ONCOLOGY, 2023, 35 (09) : e506 - e515
  • [5] Role of adjuvant and neoadjuvant chemotherapy in the treatment of transitional-cell carcinoma of bladder cancer
    Cortesi, E
    Caccarelli, F
    Luggini, A
    Nelli, F
    [J]. TUMORI JOURNAL, 2001, 87 (04): : S86 - S88
  • [6] CHEMOTHERAPY WITH CISPLATIN, EPIRUBICIN, METHOTREXATE IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC TRANSITIONAL CELL-CANCER OF THE BLADDER (TCC)
    LELLI, G
    MELOTTI, B
    PANNUTI, F
    ROSSI, AP
    MAVER, P
    MANNINI, D
    CORRADO, G
    SEVERINI, G
    BERCOVICH, E
    BEGHELLI, R
    CONCETTI, S
    MANFERRARI, F
    NANNI, P
    DESANTIS, P
    MARTINELLI, A
    TANNEBERGER, S
    [J]. JOURNAL OF CHEMOTHERAPY, 1992, 4 (04) : 239 - 243
  • [7] Feasibility study of adjuvant chemotherapy in patients with oesophageal adenocarcinoma following neoadjuvant treatment: Results of the ACES trial
    Hsu, Kristin
    Karapetis, Christos
    Bright, Tim
    Tomita, Yoko
    Singhal, Nimit
    Gowda, Raghu
    Swan, Monique
    Scott-Hoy, Alex
    Bull, Jeff
    Price, Timothy
    Roy, Amitesh
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 38 - 39
  • [8] THERMO-CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL CELL CARCINOMA OF THE BLADDER. RESULTS OF A MULTICENTRIC CLINICAL STUDY: "SYNERGO LOMBARDIA"
    Mazzoleni, Federica
    Albo, Giancarlo
    Verweij, Fabrizio
    Botteri, Edoardo
    Detti, Serena
    Colombo, Renzo
    Spasciani, Roberta
    Hurle, Rodolfo
    De Cobelli, Ottavio
    [J]. ANTICANCER RESEARCH, 2010, 30 (04) : 1538 - 1539
  • [9] NEOADJUVANT M-VAC CHEMOTHERAPY IN INVASIVE TRANSITIONAL-CELL CARCINOMA (TCC) OF THE BLADDER - A PILOT-STUDY
    SIMON, SD
    SROUGI, M
    [J]. CANCER DRUG DELIVERY, 1986, 3 (01): : 73 - 73
  • [10] Adjuvant chemotherapy in Non Small Cell Lung Cancer (NSCLC) - a feasibility study in the non-trial population
    Treece, S. J.
    Magee, L.
    Gilligan, D.
    Harden, S. V.
    [J]. LUNG CANCER, 2007, 57 : S6 - S6
12345